È
D. Schwabisch, R. Miethchen / Journal of Fluorine Chemistry 120 (2003) 85±91
90
3.8. p-Octylphenyl-(R)-4,6-O-[40-(4-
perfluorohexylsulfanyl)-benzoyloxy]-benzylidene-b-D-
glucopyranoside (11)
(m, 2H, Ph), 6.31 (d, 3J2=3 10:2 Hz, 1H, H-2 or H-3), 6.00
(m, 1H, H-1), 5.85 (dd, 1H, H-2 or H-3), 5.66 (s, 1H, acetal-
H), 4.64±4.35 (m, 2H, H-4, H-6a), 3.91 (m, 2H, H-5, H-6b);
13C NMR(75 MHz, CDCl 3): d (ppm) 164.1 (s, Cq), 159.3
(s, Ph-Cq), 151.4 (s, Ph-Cq), 139.3 (s, Ph-Ct), 137.2 (s, Ph-
Ct), 135.3 (s, Ph-Cq), 132.7 (s, Ph-Cq), 132.0, 126.7 (2s, C-2,
C-3), 131.0 (s, Ph-Ct), 127.8 (s, Ph-Ct), 121.6, 117.5 (2s, Ph-
Ct), 101.6 (s, acetal-C), 96.3 (s, C-1), 74.7, 71.2 (2s, C-4, C-
A mixture of p-octylphenyl-b-D-glucopyranoside [16]
(1.5 g, 8.15 mmol) and compound 8 (2.5 g, 4.01 mmol)
was dissolved in dry DMF (75 ml). Then methanesulfonic
acid (0.75 ml) was added and the mixture was treated as
described for compound 9. An amount of 1.2 g (32%) of
colorless crystals 11 were isolated, mp 150 8C, SA-phase, cp
5), 69.0 (s, C-6); 19F NMR(235 MHz, CDCl ): d (ppm)
3
À80.5 (s, CF3), À85.8 (m, SCF2), À87.1 (m, SCF2), À118.8
(m, CF2), À121.2 (s, CF2), À122.5 (s, CF2), À125.8 (s, CF2).
C38H20F26O6S2 (1130.65): Calcd. C: 40.37%, H: 1.78%,
S: 5.67%; found C: 40.56%, H: 1.78%, S: 5.73%.
229 8C; a24: À11.88 (CHCl3, c 1:09).
D
1H NMR(250 MHz, CDCl 3): d (ppm) 8.22 (m, 2H, Ph),
7.79 (m, 2H, Ph), 7.58 (m, 2H, Ph), 7.22 (m, 2H, Ph), 7.09
(m, 2H, Ph), 6.96 (m, 2H, Ph), 5.58 (s, 1H, acetal-H), 4.98 (d,
3
3J1=2 7:6 Hz, 1H, H-1), 4.38 (dd, J3=4 4:6 Hz,
3.10. (4-Octylphenyl)-(R)-4,6-O-[40-(4-
3J4=5 10:5 Hz, 1H, H-4), 3.94±3.73 (m, 3H, H-2, H-3
H-6a), 3.69±3.52 (m, 2H, H-5, H-6b), 2.99 (br, 1H, OH),
2.82 (br, 1H, OH), 2.55 (t, 2H, Ph-CH2), 1.59±1.26 (m, 12H,
perfluorohexylsulfanyl)-benzoyloxy]-benzylidene-2,3-
dideoxy-b-D-erythro-hex-2-enopyranoside (13)
CH2), 0.87 (t, 3H, CH3); 13C NMR(75 MHz, CDCl ): d
A mixture of 11 (0.9 g, 0.971 mmol), triphenylphosphine
(1.008 g, 3.8 mmol), triiodoimidazole (0.69 g, 1.55 mmol)
and imidazole (0.133 g, 1.96 mmol) was treated as
described for compound 12 giving 0.456 g (52.6%) color-
less crystals of compound 13. Thermotropic properties:
3
(ppm) 164.2 (s, Cq), 155.0 (s, Ph-Cq), 151.4 (s, Ph-Cq),
138.1 (s, Ph-Cq), 137.2 (s, Ph-Ct), 135.1 (s, Ph-Cq), 131.9 (s,
Ph-Cq), 131.0, 129.6, 127.9, 121.5, 116.8 (5s, Ph-Ct), 101.6
(s, C-1), 101.4 (s, acetal-C), 80.4, 74.6, 73.3, 66.6 (4s, C-2,
C-3, C-4, C-5), 68.8 (s, C-6), 35.3 (s, Ph-CH2), 32.0, 31.8,
29.6, 29.4, 29.4, 22.8 (6s, CH2), 14.3 (s, CH3); 19F NMR
(235 MHz, CDCl3); d (ppm) À80.5 (s, CF3), À85.8 (m,
SCF2), À118.8 (m, CF2), À121.1 (s, CF2), À122.5 (s, CF2),
À125.8 (s, CF2).
mp 150 8C, SA-phase, cp 214 8C, a22: 17.98 (CHCl3,
D
c 1:00).
1H NMR(250 MHz, CDCl 3): d (ppm) 8.23 (m, 2H, Ph),
7.80 (m, 2H, Ph), 7.58 (m, 2H, Ph), 7.23 (m, 2H, Ph), 7.10
(m, 2H, Ph), 7.00 (m, 2H, Ph), 6.25 (d, 3J2=3 10:1 Hz, 1H,
H-2 or H-3), 5.93 (m, 1H, H-1), 5.85 (dd, 1H, H-2 or H-3),
5.65 (s, 1H, acetal-H), 4.45±4.35 (m, 2H, H-4, H-6a), 3.91
(m, 2H, H-5, H-6b), 2.55 (t, 2H, a-CH2), 1.55±1.27 (m, 12H,
C40H39F13O8S (926.78): Calcd. C: 51.84%, H: 4.24%, S:
3.46%; found C: 51.63%, H: 4.19%, S: 3.61%.
3.9. (4-Perfluorohexylsulfanyl-phenyl)-(R)-4,6-O-[40-(4-
perfluorohexylsulfanyl)-benzoyloxy]-benzylidene-2,3-
dideoxy-b-D-erythro-hex-2-enopyranoside (12)
CH2), 0.88 (t, 3H, CH3); 13C NMR(63 MHz, CDCl ): d
3
(ppm) 163.9 (s, Cq), 154.8 (s, Ph-Cq), 151.2 (s, Ph-Cq),
137.3 (s, Ph-Cq), 137.1 (s, Ph-Ct), 135.3 (s, Ph-Cq), 131.8 (s,
Ph-Cq), 131.7, 127.6 (2s, C-2, C-3), 129.3 (s, Ph-Ct), 127.5
(s, Ph-Ct), 121.4, 116.7 (2s, Ph-Ct), 101.4 (s, acetal-C), 97.0
(s, C-1), 74.8, 70.9 (2s, C-4, C-5), 69.1 (s, C-6), 35.2, 31.9,
31.7, 29.5, 29.3, 22.7 (6s, CH2), 14.1 (s, CH3); 19F NMR
(235 MHz, CDCl3): d (ppm) À80.5 (s, CF3), À85.8 (m,
SCF2), À118.8 (m, CF2), À121.1 (s, CF2), À122.5 (s, CF2),
À125.8 (s, CF2).
A mixture of compound 9 (700 mg, 0.6 mmol), triphe-
nylphosphine (630 mg, 2.42 mmol), triiodoimidazole [19]
(431 mg, 0.97 mmol) and imidazole (83 mg, 1.23 mmol) in
dry xylene (25 ml) was stirred for 3 h at 130 8C under argon
atmosphere. After completion of the reaction (tlc-control,
eluent toluene RF 0:36), this mixture was cooled down to
room temperature, diluted with toluene (25 ml), and dec-
anted into a beaker containing saturated aq. NaHCO3-solu-
tion (150 ml). The residue was dissolved in a small volume
acetone and the solution was also added to the beaker. After
stirring for 10 min and ®ltration, the organic phase was
successively washed with 5% aq. Na2S2O3-solution, satu-
rated aq. NaHCO3-solution and water and then dried
(Na2SO4). Then the solution was concentrated under
reduced pressure and the crude product was puri®ed by
¯ash chromatography (eluent toluene RF 0:36). After
recrystallization from toluene, colorless crystals of 12
C40H37F13O6S (892.77): Calcd. C: 53.81%, H: 4.18%, S:
3.59%; found C: 53.58%, H: 4.21%, S: 3.64%.
3.11. (4-Octylphenyl)-(R)-4,6-O-[40-(4-
perfluorhexylsulfanyl)-benzoyloxy]-benzylidene-2,3-
dideoxy-b-D-erythro-hexopyranoside (14)
The ole®n 13 (300 mg, 0.336 mmol) was dissolved in
ethanol/EtOAc (1:1 (v/v), 10 ml). An amount of 20 mg of
palladium on charcoal (10%) was added. Under a hydrogen
atmosphere (1 atm) hydrogenation was carried out at room
temperature overnight. After ®ltration, the charcoal was
washed with ethanol and ethyl acetate. The combined
organic phases were concentrated under reduced pressure
and the residue was puri®ed by column chromatography
(384 mg, 56.5%) were obtained; mp 168 8C, SA-phase, cp
22
D
186 8C, a 7.48 (CHCl3, c 1:09).
1H NMR(300 MHz, CDCl 3): d (ppm) 8.23 (m, 2H, Ph),
7.80 (m, 2H, Ph), 7.58 (m, 4H, Ph), 7.24 (m, 2H, Ph), 7.12